{"id":"https://openalex.org/W7223924436","doi":"https://doi.org/10.6084/m9.figshare.c.8798485","title":"Adjuvant selection and optimization in the design of an epstein\u2013barr virus\u2013based multi-epitope vaccine against Burkitt lymphoma","display_name":"Adjuvant selection and optimization in the design of an epstein\u2013barr virus\u2013based multi-epitope vaccine against Burkitt lymphoma","publication_year":2026,"publication_date":"2026-10-27","ids":{"openalex":"https://openalex.org/W7223924436","doi":"https://doi.org/10.6084/m9.figshare.c.8798485"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.c.8798485","doi":"https://doi.org/10.6084/m9.figshare.c.8798485","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.c.8798485","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.c.8798485","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159758190","display_name":"Jesika Trimurti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I12176630","display_name":"Tanjungpura University","ror":"https://ror.org/04exz5k48","country_code":"ID","type":"education","lineage":["https://openalex.org/I12176630"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Jesika Trimurti","raw_affiliation_strings":["Tanjungpura University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tanjungpura University","institution_ids":["https://openalex.org/I12176630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091389040","display_name":"Sari Eka Pratiwi","orcid":"https://orcid.org/0000-0003-4577-8863","observed_orcids":["https://orcid.org/0000-0003-4577-8863"]},"institutions":[{"id":"https://openalex.org/I12176630","display_name":"Tanjungpura University","ror":"https://ror.org/04exz5k48","country_code":"ID","type":"education","lineage":["https://openalex.org/I12176630"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Sari Eka Pratiwi","raw_affiliation_strings":["Tanjungpura University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tanjungpura University","institution_ids":["https://openalex.org/I12176630"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099852044","display_name":"Syarifah Nurul Yanti Rizki Syahab Asseggaf","orcid":"https://orcid.org/0009-0007-4340-9614","observed_orcids":["https://orcid.org/0009-0007-4340-9614"]},"institutions":[{"id":"https://openalex.org/I12176630","display_name":"Tanjungpura University","ror":"https://ror.org/04exz5k48","country_code":"ID","type":"education","lineage":["https://openalex.org/I12176630"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Syarifah  Nurul  Yanti  Rizki  Syahab Asseggaf","raw_affiliation_strings":["Tanjungpura University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tanjungpura University","institution_ids":["https://openalex.org/I12176630"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051513108","display_name":"Ysrafil Ysrafil","orcid":"https://orcid.org/0000-0002-5980-7525","observed_orcids":["https://orcid.org/0000-0002-5980-7525"]},"institutions":[{"id":"https://openalex.org/I102347383","display_name":"University of Palangka Raya","ror":"https://ror.org/045n0ms44","country_code":"ID","type":"education","lineage":["https://openalex.org/I102347383"]}],"countries":["ID"],"is_corresponding":false,"raw_author_name":"Ysrafil Ysrafil","raw_affiliation_strings":["University of Palangka Raya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Palangka Raya","institution_ids":["https://openalex.org/I102347383"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.9409999847412109},{"id":"https://openalex.org/keywords/burkitt-lymphoma","display_name":"Burkitt lymphoma","score":0.9409999847412109},{"id":"https://openalex.org/keywords/multiepitope-vaccine","display_name":"multi-epitope vaccine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.7820000052452087},{"id":"https://openalex.org/keywords/tlr2","display_name":"TLR2","score":0.6769999861717224},{"id":"https://openalex.org/keywords/tlr4","display_name":"TLR4","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ctl-epitopes","display_name":"CTL epitopes","score":0.8759999871253967},{"id":"https://openalex.org/keywords/htl-epitopes","display_name":"HTL epitopes","score":0.9390000104904175},{"id":"https://openalex.org/keywords/b-cell-epitopes","display_name":"B-cell epitopes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gp350","display_name":"gp350","score":0.8859999775886536},{"id":"https://openalex.org/keywords/ebna1","display_name":"EBNA1","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lmp2a","display_name":"LMP2A","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bzlf1","display_name":"BZLF1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunoinformatics","display_name":"immunoinformatics","score":0.8500000238418579},{"id":"https://openalex.org/keywords/immune-simulation","display_name":"immune simulation","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.751800000667572},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6480000019073486},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.5509999990463257},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.531499981880188},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49570000171661377},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.45590001344680786},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4287000000476837},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41999998688697815},{"id":"https://openalex.org/C2779026604","wikidata":"https://www.wikidata.org/wiki/Q4774742","display_name":"Antigenicity","level":3,"score":0.4016999900341034},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3804999887943268},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.36629998683929443},{"id":"https://openalex.org/C2780801425","wikidata":"https://www.wikidata.org/wiki/Q5164392","display_name":"Construct (python library)","level":2,"score":0.36579999327659607},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3531000018119812},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.3156999945640564},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C2781241564","wikidata":"https://www.wikidata.org/wiki/Q1347450","display_name":"Epitope mapping","level":4,"score":0.30550000071525574},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2872999906539917},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.2648000121116638},{"id":"https://openalex.org/C3018913218","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody response","level":3,"score":0.2540000081062317}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.c.8798485","doi":"https://doi.org/10.6084/m9.figshare.c.8798485","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.c.8798485","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"},{"id":"doi:10.6084/m9.figshare.c.8798485.v1","doi":"https://doi.org/10.6084/m9.figshare.c.8798485.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.c.8798485.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.c.8798485","doi":"https://doi.org/10.6084/m9.figshare.c.8798485","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.c.8798485","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Collection"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7223901892","https://openalex.org/W4297200295","https://openalex.org/W4408099051","https://openalex.org/W4324145195","https://openalex.org/W7169181964","https://openalex.org/W7208710086","https://openalex.org/W2898365172","https://openalex.org/W4400881935","https://openalex.org/W4387185796","https://openalex.org/W3123558836"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"This":[2],"study":[3],"aimed":[4],"to":[5,219],"identify":[6],"and":[7,32,40,61,75,91,104,120,125,133,141,157,165,173,193,225],"optimize":[8],"a":[9,204],"multi-epitope":[10,55,85],"vaccine":[11,56,86],"construct":[12,111,187],"against":[13,210],"Epstein\u2013Barr":[14],"virus":[15],"(EBV)-associated":[16],"Burkitt":[17,212],"lymphoma,":[18],"with":[19,58,123,155],"particular":[20],"emphasis":[21],"on":[22,45,113],"adjuvant":[23],"selection,":[24],"using":[25,64],"an":[26],"immunoinformatics":[27,65],"approach.":[28],"Methods":[29],"CTL,":[30,72],"HTL,":[31,74],"B-cell":[33,77],"epitopes":[34,53,78],"derived":[35],"from":[36],"gp350,":[37],"EBNA1,":[38],"LMP2A,":[39],"BZLF1":[41],"were":[42,89],"screened":[43],"based":[44,112],"their":[46],"predicted":[47,117,136,144,170,190],"immunological":[48],"properties.":[49],"We":[50],"assembled":[51],"candidate":[52,205],"into":[54],"constructs":[57,87],"different":[59],"configurations":[60],"evaluated":[62],"them":[63],"analyses.":[66],"Results":[67],"A":[68],"total":[69],"of":[70,129],"39":[71],"21":[73],"10":[76],"met":[79],"the":[80,102,109],"predefined":[81],"selection":[82],"criteria.":[83],"Five":[84],"(R1\u2013R5)":[88],"generated":[90],"compared.":[92],"The":[93,143,184],"50":[94],"S":[95],"ribosomal":[96],"protein":[97],"L7/L12":[98],"was":[99,106,147],"selected":[100,107],"as":[101,108,203],"adjuvant,":[103],"R5":[105,127,186],"final":[110],"its":[114,201,221],"comparatively":[115],"favorable":[116,135,153,166,189],"tertiary":[118],"structure":[119],"molecular":[121,194],"interactions":[122,154],"TLR2":[124,156],"TLR4.":[126],"consisted":[128],"790":[130],"amino":[131],"acids":[132],"showed":[134],"antigenicity":[137],"(0.6479),":[138],"solubility,":[139],"non-allergenicity,":[140],"non-toxicity.":[142],"population":[145],"coverage":[146],"98.46%":[148],"worldwide.":[149],"Molecular":[150],"docking":[151],"demonstrated":[152,188],"TLR4,":[158],"while":[159],"iMODS":[160],"analysis":[161],"indicated":[162],"structural":[163],"stability":[164],"dynamic":[167],"properties.Immune":[168],"simulation":[169],"both":[171],"cellular":[172],"humoral":[174],"immune":[175],"responses":[176],"following":[177],"three":[178],"administrations":[179],"at":[180],"28-day":[181],"intervals.":[182],"Conclusion":[183],"L7/L12-adjuvanted":[185],"immunological,":[191],"structural,":[192],"characteristics":[195],"in":[196],"silico.":[197],"These":[198],"findings":[199],"support":[200],"consideration":[202],"for":[206],"further":[207],"experimental":[208,215],"investigation":[209],"EBV-associated":[211],"lymphoma.":[213],"However,":[214],"validation":[216],"is":[217],"required":[218],"determine":[220],"actual":[222],"immunogenicity,":[223],"safety,":[224],"protective":[226],"efficacy.":[227]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-28T00:00:00"}